) | |
) | |
| Names | |
|---|---|
| IUPAC name 2-(2,5-Dimethoxy-4-methylphenyl)-2-methoxyethanamine | |
| Other names 4-Methyl-2,5,β-trimethoxyphenethylamine 2-(4-Methyl-2,5,β-trimethoxyphenyl)ethanamine | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
SMILES
| |
| Properties | |
| C12H19NO3 | |
| Molar mass | 225.288 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
BOD (4-methyl-2,5,beta-trimethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy analog of 2C-D. BOD was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–25 mg, and the duration listed as 8–16 hours.[1] BOD produces strongly distorted open-eye visuals, and some closed-eye visuals. It also has an entheogenic effect and produces humor.[2] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOD.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]
See also
References
- ^ BOD Entry in PiHKAL
- ^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.